Skip to main content

Advertisement

SpringerLink
Log in

Associations of breast cancer development in patients with systemic sclerosis: an exploratory study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The goal of this study was to describe the clinical characteristics of patients with a diagnosis of systemic sclerosis who develop breast cancer and to identify associations for this relationship. From 769 patients followed at the scleroderma center of our institution over the past 16 years, 24 patients developed a diagnosis of breast cancer. The demographics and clinical characteristics of these patients will be compared to those of a randomly selected group of scleroderma patients without a diagnosis of cancer. A further analysis will compare the patients who developed their breast cancer before the diagnosis of systemic sclerosis to those diagnosed after. Twenty-four patients developed 25 breast cancers with 13 patients diagnosed before the diagnosis of systemic sclerosis and 11 after. Compared to 48 randomly selected systemic sclerosis patients without a diagnosis of cancer, the patients with breast cancer were diagnosed with systemic sclerosis at an older age (53.5 ± 15.2) as compared to those without (42.4 ± 12.5) (p = 0.002). A relatively equal amount of patients had the diffuse and limited form of systemic sclerosis, while pulmonary fibrosis (p = 0.015) and the lack of antinuclear antibody (ANA) positivity (p = 0.02) were more commonly seen in patients with breast cancer. Patients who developed breast cancer before the diagnosis of systemic sclerosis were older at systemic sclerosis diagnosis (61.6 ± 11.3) compared to those after (43.9 ± 13.5) (p = 0.03). An older age at diagnosis of systemic sclerosis, a lack of ANA positivity, and the presence of pulmonary fibrosis were more commonly seen in patients with systemic sclerosis who have a diagnosis of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jimenez SA, Derk CT (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140:37–50

    PubMed  CAS  Google Scholar 

  2. Peters-Golden M, Wise RA, Hochberg M et al (1985) Incidence of lung cancer in systemic sclerosis. J Rheumatol 12:1136–1139

    PubMed  CAS  Google Scholar 

  3. Roumm AD, Medsger TA Jr (1985) Cancer and systemic sclerosis: an epidemiological study. Arthritis Rheum 28(12):1336–1340

    Article  PubMed  CAS  Google Scholar 

  4. Abu Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36(4):460–464

    Article  PubMed  CAS  Google Scholar 

  5. Rosenthal AK, McLaughlin JK, Gridley G et al (1995) Incidence of cancer among patients with systemic sclerosis. Cancer 76:910–914

    Article  PubMed  CAS  Google Scholar 

  6. Hill CL, Nguyen AM, Roder D et al (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62:728–731

    Article  PubMed  CAS  Google Scholar 

  7. Chatterjee S, Dombi GW, Severson RK et al (2005) Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52(8):2415–2424

    Article  PubMed  Google Scholar 

  8. Derk CT, Rasheed M, Artlett CM, Jimenez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33(6):1113–1116

    PubMed  Google Scholar 

  9. Smith KJ, Yeager J, Skelton HG (1997) Localized scleroderma in breast cancer patients treated with supervoltage external beam irradiation: radiation port scleroderma. J Am Acad Dermatol 37(5):806–808

    Article  PubMed  CAS  Google Scholar 

  10. Bleasel NR, Stapleteon KM, Commens C et al (1999) Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol 40(2):99–102

    Article  PubMed  CAS  Google Scholar 

  11. Morris MM, Powell SN (1997) Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 15(7):2728–2735

    PubMed  CAS  Google Scholar 

  12. Abu-Shakra H, Lee P (1993) Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy. J Rheumatol 20(9):1601–1603

    PubMed  CAS  Google Scholar 

  13. Aref I, Cross P, Nair B (1996) Case report: severe fibrosis in a patient with scleroderma and previous radiotherapy—a case report and literature review. Br J Radiol 69(827):1055–1056

    Article  PubMed  CAS  Google Scholar 

  14. Varga J, Haustein UF, Creech RH et al (1991) Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 265(24):3292–3295

    Article  PubMed  CAS  Google Scholar 

  15. Kupfer I, Balquerie X, Courrile P et al (2003) Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 48(2):279–281

    Article  PubMed  CAS  Google Scholar 

  16. De Angelis R, Bugatti L, Cerioni A et al (2003) Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol 22(1):49–52

    Article  PubMed  Google Scholar 

  17. Battafarano DF, Zimmerman GC, Older SA et al (1995) Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases. Cancer 76(1):110–115

    Article  PubMed  CAS  Google Scholar 

  18. Dumont N, Arteaga CL (2000) Transforming growth factor-β and breast cancer. Tumor promoting effects of transforming growth factor-β. Breast Cancer Res 2:125–132

    Article  PubMed  CAS  Google Scholar 

  19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  20. Daniels CE, Jett JR (2005) Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 11(5):431–437

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Thomas Jefferson University, 613 Curtis Bldg, 1015 Walnut Street, Philadelphia, PA, 19107-5541, USA

    Chris T. Derk

Authors
  1. Chris T. Derk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris T. Derk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Derk, C.T. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 26, 1615–1619 (2007). https://doi.org/10.1007/s10067-007-0546-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0546-9

Keywords

Search

Navigation